Voluntary Benefits

Even more agreed that policymakers should come up with a new way for them to offer health benefits.

Employers who develop a flexible, cost-aware, employee-centric strategy now will be better positioned for what’s next.

Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for the wonder drugs. Today, the pressure on employers to cover them is intensifying, and I believe it will continue to as oral GLP-1 medications likely enter the market as early as next year.

They see GLP-1 agonists and biologics like Humira pushing prices up at the highest rate since at least 2010.

The direct-to-consumer pharmacy had only 33 of 79 drugs tested and only two were cheaper for the patients.

Barak Richman's team found that 33% of plan sponsors do not even ask for coverage offers from multiple contractors.